(Q61733617)

English

Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome

scientific article published on 21 December 2012

Statements

Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit